Crospovidone (PVPP) CAS NO.25249-54-1

THE COMPANY

·         Publicly traded company on the Shenzhen stock exchange (stock code 300109)

·         First domestic company to develop and manufacture PVP and PVM/MA products

·         3^rd Largest Global PVP manufacturer

·         2^nd Largest Global PVM/MA manufacturer

·         International subsidiaries in China, Europe and Japan

·         Global distribution network

OUR PRODUCTS

·         12,000 MT/year of PVP capacity

·         2,500 MT/year of PVM/MA capacity

·         12,000 MT/year GBL, 2-pyrrolidone and NVP

·         2,500 MT/year vinyl ethers

QUALITY

·         First Chinese manufacturer to be EXCiPACT^TM GMP certified

·         All pharmaceutical products manufactured under strict cGMP guidelines

·         All pharma products handled and packaged in class D cleanrooms

·         State of the art manufacturing facility (commissioned 2013)

·         QC equipment and test methods fully validated and fully audit trail compliant

ENVIRONMENTAL RESPONSIBILITY

·         Fully compliant with government requirements and regulations

·         Real time monitoring of waste streams

·         100% recycling of processing water

·         Complete conversion from coal to natural gas

·         Focus on developing green production processes

CUSTOMER and TECHNICAL SERVICE

·         Technical Research Center to assist our customer with formulation development

·         New R&D center commissioned in 2018 having integrated R&D and pilot manufacturing

·         Customer partnering to develop new opportunities

·         Strong customer and quality management services to assist our customers

NKY® is the registered trademark of Boai NKY Pharmaceuticals Ltd (NKY). KoVidone®, PolyKoVidone® and, OraRez® are the trademark names of NKY.